The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S,4R)-6,7-Dichloro-4-(5-chloro-benzo[d]isoxazol-3-ylamino)-2,2-dimethyl-chroman-3-ol ID: ALA473132
PubChem CID: 44564347
Max Phase: Preclinical
Molecular Formula: C18H15Cl3N2O3
Molecular Weight: 413.69
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)Oc2cc(Cl)c(Cl)cc2[C@@H](Nc2noc3ccc(Cl)cc23)[C@@H]1O
Standard InChI: InChI=1S/C18H15Cl3N2O3/c1-18(2)16(24)15(9-6-11(20)12(21)7-14(9)25-18)22-17-10-5-8(19)3-4-13(10)26-23-17/h3-7,15-16,24H,1-2H3,(H,22,23)/t15-,16+/m1/s1
Standard InChI Key: PTGNZWJRQOTYKB-CVEARBPZSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
6.7209 -6.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7197 -7.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4347 -7.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4329 -6.1707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1485 -6.5799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1473 -7.4132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8643 -7.8285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5872 -7.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5884 -6.5820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8667 -6.1620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9939 -8.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2982 -6.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3040 -6.1711 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8603 -5.3339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5320 -4.8544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3140 -5.1165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8046 -4.4530 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5383 -4.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3250 -3.7817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5020 -2.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8934 -2.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1049 -2.6744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9315 -3.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0061 -6.1711 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.0047 -7.8231 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.4938 -2.1202 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
9 13 1 6
3 6 2 0
10 14 1 1
1 2 2 0
14 15 1 0
15 16 2 0
5 4 2 0
4 1 1 0
16 17 1 0
17 19 1 0
18 15 1 0
5 10 1 0
6 7 1 0
18 19 2 0
7 8 1 0
19 20 1 0
8 9 1 0
20 21 2 0
9 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 18 1 0
8 11 1 0
1 24 1 0
2 25 1 0
8 12 1 0
22 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.69Molecular Weight (Monoisotopic): 412.0148AlogP: 5.47#Rotatable Bonds: 2Polar Surface Area: 67.52Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.89CX Basic pKa: 0.64CX LogP: 4.76CX LogD: 4.76Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.58Np Likeness Score: 0.04
References 1. Zhang X, Qiu Y, Li X, Bhattacharjee S, Woods M, Kraft P, Lundeen SG, Sui Z.. (2009) Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence., 17 (2): [PMID:19101153 ] [10.1016/j.bmc.2008.11.055 ]